Ryan Dunlap - 03 Jan 2024 Form 4 Insider Report for CytoDyn Inc. (CYDY)

Role
Director
Signature
/s/ Antonio Migliarese, Attorney-in-Fact for Ryan Dunlap
Issuer symbol
CYDY
Transactions as of
03 Jan 2024
Net transactions value
$0
Form type
4
Filing time
05 Jan 2024, 21:02:30 UTC
Previous filing
08 Sep 2022
Next filing
30 Oct 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYDY Non-qualified stock option (right to buy) Award $0 +800,000 $0.000000 800,000 03 Jan 2024 Common Stock 800,000 $0.2100 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 466,662 shares vested on January 3, 2024; the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) from January 2024 through May 2024.